Data for: COVID-19 Related Regulatory Change for Pharmacists – The case for its retention post the pandemic.

The delivery of healthcare including the provision of pharmacy services globally is highly regulated internationally in order to protect public health and welfare. However, the onset of the COVID-19 pandemic has precipitated the need internationally to amend the model of regulation in order to ensure that people were able to continue to access a range of healthcare services in a timely and effective manner. Many of the changes introduced to the regulation of pharmacy services in Ireland have been replicated in other countries including the introduction of electronic means to transmit prescriptions and other orders for medications, relaxing the legal restrictions in place controlling the emergency supply of prescription only medicines and more fully utilizing the professional competency of pharmacists by empowering them to use their expertise and judgment to support their patients accessing the healthcare services that they need. Many of the regulatory changes that have been introduced to support the COVID-19 public health emergency effort are ones that pharmacists have previously sought to enable them provide a more effective and expanded model of pharmaceutical care to their patients. Accordingly, many pharmacists will want these regulatory changes to be retained and further expanded in the aftermath of the COVID-19 public health emergency in order to extend their scope of practice and support them in the care of their patients全球范围内包括药房服务在内的医疗服务供给，均受到严格的国际监管，旨在保护公众健康与福祉。然而，COVID-19（新型冠状病毒肺炎）大流行的暴发，促使国际社会亟需修订监管范式，以确保民众能够及时、高效地获取各类医疗服务。爱尔兰在药房服务监管领域推出的多项改革举措，已在多国得到推广效仿，具体包括：采用电子渠道传输处方及其他药物订单、放宽针对处方药紧急供应的法定限制，以及通过赋予药师执业权限，使其能够运用专业知识与判断力辅助患者获取所需医疗服务，从而更充分地释放药师的专业能力。 诸多为支撑COVID-19公共卫生紧急事件应对工作而出台的监管改革，实则正是药师此前一直倡导推行的、可为患者提供更高效、更完善药学服务模式的相关举措。因此，在COVID-19公共卫生紧急事件结束后，众多药师都希望保留并进一步扩大这些监管改革成果，以拓展自身执业范围，更好地助力患者照护工作。